The University of Mississippi
School of Pharmacy Center for Pharmaceutical Marketing and Management

Evidence-Based DUR Initiative

Welcome

Welcome to the Evidence-Based DUR Initiative web page. The aim of this initiative is to advance the discipline of drug utilization review (DUR) for federal, state, and commercial entities by developing and championing best practices in DUR.

About MS-DUR

The Mississippi Evidence-Based DUR Initiative (MS-DUR) performs the retrospective drug utilization review (DUR) for the Mississippi Division of Medicaid. MS-DUR supports the function of the DUR Board by performing in-depth analyses using pharmacy and medical claims data to encourage evidence-based appropriate use of medications in the Mississippi Medicaid population. MS-DUR reviews claims data and monitors FDA-based safety information to ensure quality care is delivered to Medicaid beneficiaries. Based on activities of the DUR Board and claims reviews, MS-DUR provides educational outreach to health care practitioners on drug therapy to improve prescribing and dispensing practices for Mississippi Division or Medicaid beneficiaries.

What is retrospective drug utilization review (rDUR)?

The rDUR process typically consists of evaluating administrative claims data for:

  • Over/under utilization of drugs
  • Drug-drug contraindications
  • Drug-condition contraindications
  • Drug-age contraindications
  • Duplicate therapy
  • Duration of therapy
  • Clinical appropriateness
  • Education Focus

    The MS-DUR is intended to be an information sharing and education-focused entity, not a punitive program. MS-DUR provides information for health care practitioners serving Mississippi Medicaid beneficiaries to assist with the continued evaluation and management of the patient's medication requirements. The MS-DUR website has resources for providers, including the "Mississippi Medicaid Pharmacy Update" newsletters and special initiatives developed to assist providers in selecting therapy, like the "Medicaid Cough and Cold Quick List."

    Contact

    Kyle D. Null, PharmD, MS
    Research Assistant Professor
    Center for Pharmaceutical Marketing and Management
    Clinical Director, Evidence-Based DUR Initiative
    The University of Mississippi
    Faser Hall 136
    Post Office Box 1848
    University, Mississippi 38677-1848
    Office: 662-915-5948
    Fax: 662-915-5262
    kdnull@olemiss.edu

    For information about the Mississippi Medicaid DUR Program, visit http://www.medicaid.ms.gov/DUR.aspx